Performance of the fecal immunochemical test is not decreased by high ambient temperature in the rapid return system

Digestive Diseases and Sciences

Volumn 57, Issue 8, 2012, Pages 2178-2183

  Cha, Jae Myung ^a   Lee, Joung Il ^a   Joo, Kwang Ro ^a   Shin, Hyun Phil ^a   Park, Jae Jun ^a   Jeun, Jung Won ^a   Lim, Jun Uk ^a   Hwang, Sang Hyun ^b  

^a Kyung Hee University Hospital   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Colorectal cancer; Fecal immunochemical test (FIT); Mass screening; Temperature

Indexed keywords

HEMOGLOBIN;

ADULT; ANALYZER; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; FAMILY HISTORY; FECAL IMMUNOCHEMICAL TEST; FEMALE; HEMOGLOBIN DETERMINATION; HIGH TEMPERATURE; HUMAN; LABORATORY TEST; LOW TEMPERATURE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; SCREENING TEST; SEASONAL VARIATION; SENSOR;

AGED; COLORECTAL NEOPLASMS; FECES; FEMALE; HUMANS; IMMUNOLOGIC TESTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TEMPERATURE;

EID: 84866401206     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2139-y     Document Type: Article

References (22)

1. Choi KS, Jun JK, Lee HY, Hahm MI, Oh JH, Park EC. Increasing uptake of colorectal cancer screening in Korea: a populationbased study. BMC Public Health. 2010;10:265.
2. Shim JI, Kim Y, Han MA, et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat. 2010;42:191-198.
3. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening of colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311-1318.
4. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occultblood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-1607.
5. Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341: 736-740.
6. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-1371.
7. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
8. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecaloccult- blood test. Lancet. 1996;348:1467-1471.
9. Jørgensen OD, Kronborg O, Fenger C. A randomized study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29-32.
10. Young GP, John DJ, Winawer SJ, Rozen P, WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood test for screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002;97:2499-2507.
11. Young GP, Sinatra MA, John DJ. Influence of delay in stool sampling on fecal occult blood test sensitivity. Clin Chem. 1996; 42:1107-1108.
12. Vilkin A, Rozen P, Levi Z, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol. 2005;100:2519-2525.
13. Grazzini G, Ventura L, Zappa M, et al. Influence of seasonal variation in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from Florence district. Gut. 2010;59:1511-1515.
14. Yoo KY. Cancer control activities in the republic of Korea. Jpn J Clin Oncol. 2008;38:327-333.
15. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406-1422.
16. Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med. 2005;20:278-282.
17. Fenocchi E, Martinez L, Tolve J, et al. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev. 2006;15:384-390.
18. Rubeca T, Rapi S, Confortini M, et al. Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB gold and OC sensor assays in a consecutive prospective screening series. Int J Biol Markers. 2006;21:157-161.
19. Grazzini G, Gastiglione G, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev. 2004;13:19-26.
20. Sohn DK, Jeong SY, Choi HS, et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat. 2005;37:20-23.
21. Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen. 2002;9:99-103.
22. Rennert G. Colorectal cancer screening: will global warming affect the accuracy of FIT testing? Gut. 2010;59:1451-1452.